No discrete molecular drug target

The term 'No discrete molecular drug target' refers to a category of pharmacological agents that achieve their therapeutic effect through physical or chemical interactions rather than by binding to a specific biological macromolecule like a protein or nucleic acid. These agents operate outside the classical occupancy theory of drug action, where the effect is typically proportional to the fraction of receptors bound. Common examples include antacids, which neutralize stomach acid through a direct chemical reaction, and osmotic diuretics or laxatives, which utilize physical osmotic pressure to shift fluid balance (StatPearls, 'Antacids', 2023; StatPearls, 'Mannitol', 2023). Other examples include activated charcoal, which works via physical adsorption of substances in the gastrointestinal tract to prevent systemic absorption (NIH, 'Activated Charcoal'). Because these drugs lack a specific molecular target, their effects are often localized and dependent on the bulk concentration or physical properties of the substance. This classification is vital for understanding drugs that provide clinical benefit through non-biological pathways and require different pharmacokinetic and pharmacodynamic modeling approaches compared to traditional targeted therapies.

Other names

Non-specific drug targetPhysical/chemical mechanism of actionNon-receptor mediated actionNon-molecular target

Drugs in this category act through physical or chemical means rather than binding to a specific molecular receptor. Mechanisms include chemical neutralization of gastric acid, creation of osmotic gradients to move water, physical adsorption of toxins, or alteration of surface tension in the gastrointestinal tract (Rang & Dale's Pharmacology, 9th Edition, 2019; Goodman & Gilman's The Pharmacological Basis of Therapeutics, 13th Edition, 2017).